Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others
出版年份 2016 全文链接
标题
Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others
作者
关键词
-
出版物
JNCI-Journal of the National Cancer Institute
Volume 108, Issue 9, Pages djw050
出版商
Oxford University Press (OUP)
发表日期
2016-04-30
DOI
10.1093/jnci/djw050
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer
- (2016) Robert C Stein et al. HEALTH TECHNOLOGY ASSESSMENT
- The agreement chart
- (2013) Shrikant I Bangdiwala et al. BMC Medical Research Methodology
- Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy
- (2013) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population
- (2013) Dennis C Sgroi et al. LANCET ONCOLOGY
- PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2
- (2012) G C Wishart et al. BRITISH JOURNAL OF CANCER
- A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen
- (2012) S. K. Chia et al. CLINICAL CANCER RESEARCH
- Selecting Breast Cancer Patients for Chemotherapy: The Opening of the UK OPTIMA Trial
- (2012) J. Bartlett et al. CLINICAL ONCOLOGY
- Agreement in Risk Prediction Between the 21-Gene Recurrence Score Assay (Oncotype DX(R)) and the PAM50 Breast Cancer Intrinsic Classifier in Early-Stage Estrogen Receptor-Positive Breast Cancer
- (2012) C. M. Kelly et al. ONCOLOGIST
- A population-based validation of the prognostic model PREDICT for early breast cancer
- (2011) G.C. Wishart et al. EJSO
- Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer
- (2011) Jack Cuzick et al. JOURNAL OF CLINICAL ONCOLOGY
- Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial
- (2011) John M.S. Bartlett et al. JOURNAL OF CLINICAL ONCOLOGY
- Microarray-Based Class Discovery for Molecular Classification of Breast Cancer: Analysis of Interobserver Agreement
- (2011) Alan Mackay et al. JNCI-Journal of the National Cancer Institute
- Practical implications of gene-expression-based assays for breast oncologists
- (2011) Aleix Prat et al. Nature Reviews Clinical Oncology
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study
- (2010) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast cancer molecular profiling with single sample predictors: a retrospective analysis
- (2010) Britta Weigelt et al. LANCET ONCOLOGY
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started